Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Microbiology (Reading) ; 167(3)2021 03.
Article in English | MEDLINE | ID: mdl-33529150

ABSTRACT

Amphibians have declined around the world in recent years, in parallel with the emergence of an epidermal disease called chytridiomycosis, caused by the chytrid fungus Batrachochytrium dendrobatidis (Bd). This disease has been associated with mass mortality in amphibians worldwide, including in Costa Rica, and Bd is considered an important contributor to the disappearance of this group of vertebrates. While many species are susceptible to the disease, others show tolerance and manage to survive infection with the pathogen. We evaluated the pathogen Bd circulating in Costa Rica and the capacity of amphibian skin bacteria to inhibit the growth of the pathogen in vitro. We isolated and characterized - genetically and morphologically - several Bd isolates from areas with declining populations of amphibians. We determined that the circulating chytrid fungus in Costa Rica belongs to the virulent strain Bd-GPL-2, which has been related to massive amphibian deaths worldwide; however, the isolates obtained showed genetic and morphological variation. Furthermore, we isolated epidermal bacteria from 12 amphibian species of surviving populations, some in danger of extinction, and evaluated their inhibitory activity against the collection of chytrid isolates. Through bioassays we confirmed the presence of chytrid-inhibitory bacterial genera in Costa Rican amphibians. However, we observed that the inhibition varied between different isolates of the same bacterial genus, and each bacterial isolation inhibited fungal isolation differently. In total, 14 bacterial isolates belonging to the genera Stenotrophomonas, Streptomyces, Enterobacter, Pseudomonas and Klebsiella showed inhibitory activity against all Bd isolates. Given the observed variation both in the pathogen and in the bacterial inhibition capacity, it is highly relevant to include local isolates and to consider the origin of the microorganisms when performing in vivo infection tests aimed at developing and implementing mitigation strategies for chytridiomycosis.


Subject(s)
Amphibians/microbiology , Antibiosis , Bacteria/genetics , Batrachochytrium/growth & development , Mycoses/veterinary , Animals , Bacteria/classification , Bacteria/isolation & purification , Bacterial Physiological Phenomena , Batrachochytrium/physiology , Costa Rica , Endangered Species , Genotype , Microbiota , Mycoses/microbiology , Phylogeny
2.
J Appl Toxicol ; 41(3): 387-398, 2021 03.
Article in English | MEDLINE | ID: mdl-32830870

ABSTRACT

Emerging infectious diseases are major drivers of global and local amphibian biodiversity loss. Therefore, developing effective disinfection methods to manage the impact of diseases in wild and captive "ark" populations are an important goal in amphibian conservation. While chemical disinfectants have been used safely and effectively in larval and adult amphibians infected with pathogenic microbes, their applicability to amphibian egg masses has remained untested. To bridge this gap, we exposed embryos of the common toad (Bufo bufo) and agile frog (Rana dalmatina) experimentally to three widely used disinfectants: voriconazole, chloramphenicol and chlorogen-sesquihydrate. For 3 days we exposed portions of egg masses to these disinfectants at 1×, 2×, 5× and 10× the concentration recommended for the disinfection of tadpoles and adults. Subsequently, we recorded embryonic and larval survival, as well as larval body mass and the incidence of abnormalities 12 days after hatching. Application of voriconazole had species- and concentration-dependent negative impacts on survival and body mass, and caused marked malformations in the viscerocranial structure of B. bufo tadpoles. Exposure to chlorogen-sesquihydrate also resulted in significant mortality in B. bufo embryos and negatively affected body mass of R. dalmatina larvae. Chloramphenicol had little negative effects on embryos or larvae in either species. Based on these results, the application of voriconazole and chlorogen-sesquihydrate cannot be recommended for the disinfection of amphibian eggs, whereas treatment with chloramphenicol appears to be a safe method for eliminating potential pathogens from anuran egg masses and their immediate aquatic environment.


Subject(s)
Batrachochytrium/growth & development , Disinfectants/toxicity , Embryo, Nonmammalian/drug effects , Larva/drug effects , Larva/growth & development , Ovum/drug effects , Ovum/growth & development , Ranidae/embryology , Animals , Chloramphenicol/toxicity , Hungary , Voriconazole/toxicity
3.
PLoS One ; 15(10): e0240480, 2020.
Article in English | MEDLINE | ID: mdl-33079945

ABSTRACT

Global amphibian populations are being decimated by chytridiomycosis, a deadly skin infection caused by the fungal pathogens Batrachochytrium dendrobatidis (Bd) and B. salamandrivorans (Bsal). Although ongoing efforts are attempting to limit the spread of these infections, targeted treatments are necessary to manage the disease. Currently, no tools for genetic manipulation are available to identify and test specific drug targets in these fungi. To facilitate the development of genetic tools in Bd and Bsal, we have tested five commonly used antibiotics with available resistance genes: Hygromycin, Blasticidin, Puromycin, Zeocin, and Neomycin. We have identified effective concentrations of each for selection in both liquid culture and on solid media. These concentrations are within the range of concentrations used for selecting genetically modified cells from a variety of other eukaryotic species.


Subject(s)
Amphibians/microbiology , Antifungal Agents/pharmacology , Batrachochytrium/drug effects , Batrachochytrium/growth & development , Mycology/methods , Animals , Batrachochytrium/genetics , Bleomycin/pharmacology , Cinnamates/pharmacology , Diagnostic Tests, Routine , Drug Evaluation, Preclinical , Hygromycin B/analogs & derivatives , Hygromycin B/pharmacology , Microbial Sensitivity Tests , Neomycin/pharmacology , Puromycin/pharmacology , Pyrrolidinones/pharmacology , Selection, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...